Cutaneous melanoma
descriptive epidemiological study
Keywords:
Melanoma, Epidemiology, Sex distribution, Limbs, Survival rateAbstract
CONTEXT AND OBJECTIVE: Cutaneous melanoma represents around 3% of all skin tumors. About 20% of such patients will have advanced disease and will die before reaching five years of survival. The aim of this paper was to describe the clinical and histopathological variables and their correlations. DESIGN AND SETTING: Retrospective, descriptive, epidemiological study at the Melanoma Unit, Dermatological Clinic, Irmandade da Santa Casa de Misericórdia, São Paulo. METHODS: Records from 364 cases between May 1993 and January 2006 were analyzed. The frequencies of all study variables and their 95% confidence intervals were determined. The chi-squared test was used to evaluate associations among the variables, adopting a significant level of 0.05. RESULTS: Females predominated, with 1.4 women for each man. The patients’ mean age was 58.9 years. Nonwhite patients represented 13.7% of the sample. The prevalent anatomical sites for cutaneous melanoma were the trunk and feet, for both men and women. Acral lentiginous melanoma represented 22.3% of the cohort. In situ primary lesions were observed in few cases and a high percentage of thick cutaneous melanoma was detected. Ulceration was found in 13.4% of the thin tumors (≤ 1.0 mm). Thicker and ulcerated lesions predominated in male patients (p = 0.011 and p < 0.001 respectively) and in elderly patients (p = 0.021 and p = 0.015). CONCLUSIONS: The cohort mostly presented thick and ulcerated tumors, denoting late diagnosis and bad prognosis. Also, the sample was characterized by considerable prevalence of female patients, nonwhite patients, limb lesions and acral lentiginous melanoma.
Downloads
References
Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin. 1996;46(1):5-27.
Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag; 2002.
Mikkilineni R, Weinstock MA. Epidemiology. In: Sober A, Haluska F, editors. Skin cancer. London: BC Decker; 2001. p. 1-15.
Bakos L. Melanomas malignos e etnia. [Malignant melanoma and race]. An Bras Dermatol. 1991;66(6):299-302.
Lucas EA, Deps PD, Lima JGB, Toribio R, Gomes CC. Melanoma maligno: estudo casuístico retrospectivo de 1982 a 1992, no Hospital Universitário da UFES. [Malignant melanoma: retrospective study in the period 1982-1992, in the University Hospital of UFES]. Arq Bras Med. 1994;68(2):67-70.
Fernandes NC, Cardoso ICL, Maceira J, Perez M. Melanoma: estudo retrospectivo de 47 casos. An Bras Dermatol. 1996;71(5):381-5. Available from: http://www. anaisdedermatologia.org.br/artigo.php?artigo_id=1107 Accessed in 2007 (Nov 23).
Giavina-Bianchi MH, Festa Neto C, Sanches Jr JA, et al. Análise de 115 casos de melanoma. Jornal Dermatológico da Sociedade Brasileira de Dermatologia (SBD). 1996;74:4-5.
Bernardi CDV, Favaretto AL, Brancher MC, Ponzio HA. Freqüência de melanoma maligno no Serviço de Dermatologia da ISCMPA/UFRGS. [Rate of malignant melanoma in Service of Dermatology of ISCMPA/UFRGS]. An Bras Dermatol. 1998;73(Supl 1):8.
Criado PR, Vasconcellos C, Sittart JAS, et al. Melanoma maligno cutâneo primário: estudo retrospectivo de 1963 a 1997 no Hospital do Servidor Público Estadual de São Paulo. [Primary cutaneous malignant melanoma occurrence diagnosed at Hospital do Servidor Público Estadual de São Paulo between the period from 1963 through 1997]. Rev Assoc Med Bras (1992). 1999;45(2):157-62.
Bakos L, Wagner M, Bakos RM, et al. Sunburn, sunscreens and phenotypes: some risk factors for cutaneous melanoma in southern Brazil. Int J Dermatol. 2002;41(9):557-62.
Gon AS, Minelli L, Guembarovski AL. Melanoma cutâneo primário em Londrina. [Primary cutaneous melanoma in Londrina]. An Bras Dermatol. 2001;76(4):413-26.
Lapa MS, Guedes KF, Schalch FO, Landman G. Melanomas malignos cutâneos tratados no Hospital do Câncer de São Paulo: Estudo retrospectivo para avaliação de distribuição, fatores prognósticos e sobrevida. [Cutaneous malignant melanomas treated at the Hospital do Cancer in São Paulo: Retrospective study for the evaluation of distribution, prognostic factors and survival]. An Bras Dermatol. 2002;77(3):313-20.
Pinheiro AMCF, Horácio C, Rodrigues ALSV, Abe H. Melanoma cutâneo: características clínicas, epidemiológicas e histopatológicas no Hospital Universitário de Brasília entre janeiro de 1994 e abril de 1999. [Cutaneous melanoma: clinical, epidemiological and histopathological characteristics at the University Hospital of Brasília between January 1994 and April 1999]. An Bras Dermatol. 2003;78(2):179-86.
Moreno M. Perfil dos pacientes com melanoma cutâneo no oeste de Santa Catarina, Brasil. Grupo Brasileiro de Melanoma. Boletim Informativo do GBM. 2005;3(31):3. Available from: http://www.gbm.org.br/gbm/boletim/2005/infor31.aspx Accessed in 2008 (Jan 15).
Marrett LD, Nguyen HL, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int J Cancer. 2001;92(3):457-62.
Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001;93(9):678-83.
Instituto Brasileiro de Geografia e Estatística (IBGE). Censo 2000. [Internet] [cited 2006, Mar 13]. População residente, por situação do domicílio e sexo, segundo os grupos de idade - Brasil Available from: http://www.ibge.gov.br/home/estatistica/populacao/censo2000/tabelabrasil111.shtm. Accessed in 2008 (Jan 15).
Weinstock MA, Berwick M. Epidemiology: Current Trends. In: Balch CM, Houghton AN, Sober AJ, Soong S, editors. Cutaneous melanoma. 4th ed. Saint Louis: Quality Medical Publishing; 2003. p. 18.
National Program of Cancer Registries (NPCR). United States Cancer Statistics (USCS). [Year: 2002.Display: By Cancer Type & Race (crude)] Crude Invasive Cancer Incidence Rates and 95% Confidence Intervals by Primary Site and Race and Ethnicity, United States (Table 1.1.2.1M). Available from: http://apps.nccd.cdc.gov/uscs/Table.aspx?Group=TableAll&Year=2004&Display=n. Accessed in 2007 (Jan 15).
Australian Institute of Health and Welfare. Cancer in Australia 1997: Incidence and mortality data for 1997 and selected data for 1998 and 1999. Available from: http://www.aihw.gov.au/publications/can/ca97/ca97_c01.pdf. Accessed in 2007 (Nov 23).
Venegas LFP, Flores C, Blacher GG, Daudt AW, Cerski CTS. Melanoma maligno cutâneo no Rio Grande do Sul: estudo de 101 casos. [Cutaneous malignant melanoma in Rio Grande do Sul, Brazil: study of 101 cases]. Rev Assoc Med Bras (1992). 1992;38(3):122-6.
Bandiera DC, Prudente A. Melanoma maligno. In: Roxo Nobre MO, Junqueira ACC, editors. Cancerologia prática. São Paulo: Fundo Editorial Procienx; 1967. p. 228-40.
Donato CA, Yokomizo V, Peres Rosa I. Melanoma maligno: avaliação de 58 casos em um período de 11 anos (jan/85 - dez/95). Med Cutan Ibero Lat Am. 1997;25:265-9.
Brandão M, Filardi F, Domenech J, et al. Melanoma cutâneo. Grupo Brasileiro de Melanoma. Boletim Informativo do GBM. 1998;1(1):2. Available from: http://www. gbm.org.br/gbm/boletim/1998/infor01.aspx Accessed in 2008 (Jan 14).
Minelli L, Pereira VL. Melanoma - estudo casuístico do Instituto do Câncer de Londrina. [Melanoma: case study at the Instituto de Cancer de Londrina]. An Bras Dermatol. 1983;58(2):81-4.
Reintgen DS, McCarty KM Jr, Cox E, Seigler HF. Malignant melanoma in black American and white American populations. A comparative review. JAMA. 1982;248(15):1856-9.
Seiji M, Takahashi M. Acral melanoma in Japan. Hum Pathol. 1982;13(7):607-9.
Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83(8):1664-78.
Sober AJ, Tsao H. Acquired precursor lesions and markers of increased risk for cutaneous melanoma. In: Balch CM, Houghton AN, Sober AJ, Soong S, editors. Cutaneous melanoma. 4th ed. Saint Louis: Quality Medical Publishing; 2003. p. 122.
Dennis LK. Analysis of the melanoma epidemic, both apparent and real: data from 1973 through 1994 surveillance, epidemiology, and end results, program registry. Arch Dermatol. 1999;135(3):275-80.
Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19(16):3622-34.
